GL Biochem (Shanghai) (revision 16)
Old revision·22:39, 16 Aug 2024·UnderfillUna
| GL Biochem (Shanghai) Ltd. | |
|---|---|
| Legal name | GL Biochem (Shanghai) Ltd. |
| Trading name | GL Biochem |
| Other designations | GLS |
| Organisation infobox · conventions | |
GL Biochem (Shanghai) Ltd. (trading as GL Biochem; glbiochem.net) is a peptide-synthesis company based in Shanghai, China, described in available sources as founded in 1998 and operating at a scale substantially larger than the research-compound suppliers otherwise covered on this wiki, supplying custom peptides and amino acid derivatives internationally.[1][2]
The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]Available sources describe the organisation as founded in 1998, which would make it the oldest entity covered on this wiki and place its establishment two decades before the current research-compound retail market.[2] It is described as holding ISO 9001 certification and operating under a cGMP quality system, with a workforce in the low thousands and a substantial patent portfolio.[2]
Those figures come from the organisation's own material and are reproduced here as attributed claims rather than as verified facts, in accordance with Project:Verifiability. They are unusually specific for this sector, and a certification claim in particular is not a fact until assessed against the applicable framework.[5]
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
References
- ^ National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ a b c Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ World Health Organization, Good Manufacturing Practices for Pharmaceutical Products: Main Principles, WHO Technical Report Series. The general framework against which a GMP claim is assessed.